Haejung Won

765 total citations
12 papers, 563 citations indexed

About

Haejung Won is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Haejung Won has authored 12 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Haejung Won's work include Cancer Immunotherapy and Biomarkers (5 papers), Immune cells in cancer (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Haejung Won is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immune cells in cancer (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Haejung Won collaborates with scholars based in United States, China and Poland. Haejung Won's co-authors include Marcin Kortylewski, Dayson Moreira, Sumanta K. Pal, Priyanka Duttagupta, Stephen J. Forman, Dewan Md Sakib Hossain, Qifang Zhang, Massimo D’Apuzzo, Jeremy Jones and Vijayalakshmi Nandakumar and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Haejung Won

12 papers receiving 562 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haejung Won United States	10	311	293	213	90	78	12	563
Emilie Laprévotte France	9	347 1.1×	283 1.0×	188 0.9×	34 0.4×	116 1.5×	13	648
Teresita L. Arenzana United States	9	206 0.7×	179 0.6×	292 1.4×	58 0.6×	64 0.8×	10	547
Marlies Vanden Bempt Belgium	8	303 1.0×	356 1.2×	299 1.4×	63 0.7×	116 1.5×	9	673
Е. P. Kisseleva Russia	5	200 0.6×	262 0.9×	228 1.1×	95 1.1×	77 1.0×	17	504
Lucia Bongiovanni Italy	12	175 0.6×	153 0.5×	189 0.9×	53 0.6×	102 1.3×	18	427
Erin A. Brunazzi United States	6	634 2.0×	438 1.5×	228 1.1×	86 1.0×	149 1.9×	8	896
Budiman Kharma Japan	10	273 0.9×	335 1.1×	165 0.8×	60 0.7×	67 0.9×	12	577
Maria Corallo Italy	8	106 0.3×	300 1.0×	182 0.9×	35 0.4×	83 1.1×	11	455
Francesca Amicarella Switzerland	8	263 0.8×	273 0.9×	86 0.4×	43 0.5×	52 0.7×	10	436

Countries citing papers authored by Haejung Won

Since Specialization

Citations

This map shows the geographic impact of Haejung Won's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haejung Won with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haejung Won more than expected).

Fields of papers citing papers by Haejung Won

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haejung Won. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haejung Won. The network helps show where Haejung Won may publish in the future.

Co-authorship network of co-authors of Haejung Won

This figure shows the co-authorship network connecting the top 25 collaborators of Haejung Won. A scholar is included among the top collaborators of Haejung Won based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haejung Won. Haejung Won is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Moreira, Dayson, Sagus Sampath, Haejung Won, et al.. (2020). Myeloid cell–targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell–mediated immunity. Journal of Clinical Investigation. 131(2). 71 indexed citations

Pal, Sumanta K., Dayson Moreira, Haejung Won, et al.. (2019). Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy. International Journal of Molecular Sciences. 20(8). 1831–1831. 40 indexed citations

Zhao, Xingli, Zhuoran Zhang, Dayson Moreira, et al.. (2018). B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors. Molecular Therapy. 26(3). 695–707. 26 indexed citations

Sampath, Sagus, Haejung Won, Erminia Massarelli, et al.. (2018). Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients. Oncotarget. 9(13). 11279–11290. 20 indexed citations

Gong, Jun, Nazlı Dizman, Valeriy Poroyko, et al.. (2018). Gut microbiome composition and response to sunitinib in metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 36(6_suppl). 657–657. 3 indexed citations

Maia, Manuel Caitano, Valeriy Poroyko, Haejung Won, et al.. (2018). Association of microbiome and plasma cytokine dynamics to nivolumab response in metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 36(6_suppl). 656–656. 11 indexed citations

Won, Haejung, Dayson Moreira, Chan Gao, et al.. (2017). TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs. Journal of Leukocyte Biology. 102(2). 423–436. 49 indexed citations

Won, Haejung, Sagus Sampath, Erminia Massarelli, Ellie Maghami, & Marcin Kortylewski. (2017). Abstract 35: Chemo-radiotherapy induces tolerogenic STAT3 signaling in circulating myeloid-derived suppressor cells in patients with head and neck squamous cell carcinoma (HNSCC). Clinical Cancer Research. 23(23_Supplement). 35–35. 1 indexed citations

Zhang, Qifang, Dewan Md Sakib Hossain, Priyanka Duttagupta, et al.. (2016). Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia. Blood. 127(13). 1687–1700. 66 indexed citations

10.

Hossain, Dewan Md Sakib, Sumanta K. Pal, Dayson Moreira, et al.. (2015). TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients. Clinical Cancer Research. 21(16). 3771–3782. 156 indexed citations

11.

Won, Haejung, et al.. (2014). Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1. Blood. 124(17). 2647–2656. 42 indexed citations

12.

Jiang, Xiaoxia, Quan Nguyen, Tao Wang, et al.. (2011). Control of B Cell Development by the Histone H2A Deubiquitinase MYSM1. Immunity. 35(6). 883–896. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact